The Prevalence of Low-Value Prostate Cancer Screening in Primary Care Clinics: A Study Using the National Ambulatory Medical Care Survey
Conclusions:
The use of low-value PSAs and DREs was sizable during the observed time period. Organizations who want to reduce low-value PSAs and DREs may want to focus interventions on providers who order a high number of tests.
Source: Journal of the American Board of Family Medicine - Category: Primary Care Authors: Gillette, C., Garvick, S., Bates, N., Martin, C. M., Hanchate, A., Reuland, D. S. Tags: Brief Report Source Type: research
More News: Cancer | Cancer & Oncology | Health Management | Information Technology | Medicare | Primary Care | Prostate Cancer | Study | USA Health